Back to News
Market Impact: 0.35

Peter Lynch Detailed Fundamental Analysis

BDXNDAQ
Company FundamentalsAnalyst InsightsHealthcare & Biotech
Peter Lynch Detailed Fundamental Analysis

Validea's guru fundamental report indicates Becton Dickinson (BDX) receives a 91% rating based on their Peter Lynch P/E/Growth Investor model, signaling strong interest due to the firm's fundamentals and valuation. The analysis, based on Lynch's strategy of identifying companies trading at reasonable prices relative to earnings growth with strong balance sheets, highlights that BDX passes key tests including P/E/Growth ratio, sales and P/E ratio, inventory to sales, EPS growth rate, and total debt/equity ratio.

Analysis

Becton Dickinson and Co (BDX), a large-cap growth stock in the Medical Equipment & Supplies industry, has garnered a 91% rating from Validea's P/E/Growth Investor model, based on Peter Lynch's strategy, indicating strong interest. This model favors companies with reasonable price-to-earnings growth (PEG) ratios and robust balance sheets. BDX meets several key criteria, demonstrating positive performance in its P/E/Growth ratio, sales and P/E ratio, inventory to sales management, EPS growth rate, and total debt/equity ratio. These factors contribute to the strongly positive sentiment (0.85 score for BDX) associated with the stock based on this specific analytical framework. However, the report also highlights neutral assessments for BDX's free cash flow and net cash position, suggesting these areas may not align as strongly with the ideal Lynch criteria or warrant further monitoring.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.75

Ticker Sentiment

BDX0.85
NDAQ0.00

Key Decisions for Investors

  • Investors employing a growth-at-a-reasonable-price (GARP) strategy, similar to Peter Lynch's, may find BDX an attractive candidate given its high model rating and favorable metrics on key growth and financial health indicators.
  • It is advisable to scrutinize BDX's free cash flow generation and net cash position, as these were rated neutral and could influence long-term financial flexibility despite strengths in other fundamental areas.
  • Given the overall positive assessment and the stock passing multiple tests of a historically successful investment strategy, BDX could be considered for addition to growth-oriented portfolios, with ongoing monitoring of the aforementioned neutral financial metrics.